Vivos Therapeutics shares are trading lower after the company announced the pricing of a $4 million private placement.
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has announced the pricing of a $4 million private placement, causing its shares to trade lower.
October 31, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Vivos Therapeutics' stock is trading lower after the company announced a $4 million private placement.
The announcement of a private placement often leads to a decrease in share price as it dilutes the value of existing shares. In this case, Vivos Therapeutics' announcement of a $4 million private placement has led to a decrease in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100